GeneFerm Biotechnology Co Ltd Financial Flexibility Index
GeneFerm Biotechnology Co Ltd financial flexibility index. GeneFerm Biotechnology Co Ltd (1796) has a Financial Flexibility Index of 0.02x as of June 2025. Free cash flow of NT$7.43 Million (operating CF NT$1.45 Million minus capex NT$5.98 Million) represents 0% of total liabilities (NT$453.10 Million). See 1796 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of GeneFerm Biotechnology Co Ltd (2017–2024)
Financial flexibility index of GeneFerm Biotechnology Co Ltd from 2017 to 2024. Historical Financial Flexibility Index trend for GeneFerm Biotechnology Co Ltd across 8 annual periods. Check how high is GeneFerm Biotechnology Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
GeneFerm Biotechnology Co Ltd Financial Flexibility Index by Year (2017–2024)
GeneFerm Biotechnology Co Ltd financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for GeneFerm Biotechnology Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of GeneFerm Biotechnology Co Ltd.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.09x | NT$30.79 Million | NT$8.09 Million | NT$358.31 Million | ▼ -90.7% |
| 2023 | 0.93x | NT$261.72 Million | NT$190.31 Million | NT$282.54 Million | ▼ -17.1% |
| 2022 | 1.12x | NT$400.85 Million | NT$122.43 Million | NT$358.86 Million | ▲ +146.6% |
| 2021 | 0.45x | NT$257.84 Million | NT$112.23 Million | NT$569.22 Million | ▲ +91.4% |
| 2020 | 0.24x | NT$138.74 Million | NT$56.42 Million | NT$586.38 Million | ▼ -84.3% |
| 2019 | 1.51x | NT$69.26 Million | NT$14.69 Million | NT$46.00 Million | ▲ +198.6% |
| 2018 | 0.50x | NT$70.94 Million | NT$42.14 Million | NT$140.69 Million | ▼ -15.9% |
| 2017 | 0.60x | NT$116.23 Million | NT$61.08 Million | NT$193.79 Million | — |